PHARMA, PHYSICIAN NEXUS -A PERIL IN THE OFFING
DOI:
https://doi.org/10.55519/JAMC-04-12530Keywords:
Pharmaceutical Collaboration, Healthcare, Ethics, Sponsorship, PakistanAbstract
Pharmaceutical companies and healthcare professionals have long been a subject of scrutiny, as their collaboration plays a pivotal role in advancing medical research, promoting evidence-based practices, and fostering dialogue among healthcare practitioners. Together, they have pushed the boundaries of scientific innovation, paving the way for groundbreaking medical advancements. However, ethical concerns arise when such collaborations cross the line into lavish sponsorships for physicians, including all-expenses-paid trips to international conferences and seminars. The opaque ties between the pharmaceutical industry and Physicians cast a shadow on the sanctity of impartial medical practice, particularly in a nation like Pakistan where regulatory frameworks are a work in progress. While the undeniable benefits of collaboration between pharmaceutical companies and medical practitioners are evident, it is imperative to address the ethical implications when such partnerships tread perilously close to the line between ethical collaboration and ethically questionable practices.References
Nie, J., Yu, C., Zou, X., Gong, N., Tucker, J. D., Wong, B. C., & Kleinman, A. (2017). The vicious circle of patient-physician mistrust in China: health professionals’ perspectives, institutional conflict of interest, and building trust through medical professionalism. Developing World Bioethics, 18(1), 26–36. https://doi.org/10.1111/dewb.12170
Smith, R. (1998). Beyond conflict of interest. BMJ, 317(7154), 291–292. https://doi.org/10.1136/bmj.317.7154.291
Yousafzai, A. W. (2015). Corruption in medical practice: Where do we stand? ResearchGate. https://www.researchgate.net/publication/283889613_Corruption_in_medical_practice_Where_do_we_stand
De Andrade, M., Jafarey, A., Shekhani, S. S., & Angelova, N. (2018). The Ethics of Pharma–Physician Relations in Pakistan: “When in Rome.” Ethics & Behavior, 29(6), 473–489. https://doi.org/10.1080/10508422.2018.1481751
Lo, B., & Field, M. J. (2009). Conflict of Interest in Medical Research, Education, and Practice. In National Academies Press eBooks. https://doi.org/10.17226/12598
Kasaw Adane, Ligabaw Worku, Teshiwal Deress et al. Ethical practice in medicine: a review, 29 January 2020, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.2.22243/v1]
Vassilas, C. A., & Matthews, S. (2006). Pharmaceutical sponsorship of educational events: what can we learn from healthcare ethics? Psychiatric Bulletin. https://doi.org/10.1192/pb.30.5.189
Ohta, R., & Sano, C. (2023). Overcoming ethical issues surrounding the relationships between physicians and pharmaceutical companies in rural hospitals. Cureus. https://doi.org/10.7759/cureus.43320
Thompson, D. F. (2017b). Understanding financial conflicts of interest. In Routledge eBooks (pp. 505–508). https://doi.org/10.4324/9781315244426-5
Nelson, B. (2014). A trip to remember, with strings attached: Researchers begin sorting through the tangled ethical and legal implications of medical tourism. Cancer Cytopathology, 122(11), 787–788. https://doi.org/10.1002/cncy.21493
Lexchin, J. (2012b). Sponsorship bias in clinical research. The International Journal of Risk and Safety in Medicine, 24(4), 233–242. https://doi.org/10.3233/jrs-2012-0574
Komesaroff, P. A. (2005). Ethical issues in the relationships involving medicine and industry: evolving problems require evolving. Internal Medicine Journal, 35(4), 203–205. https://doi.org/10.1111/j.1445-5994.2005.00807.x
Upholding patient rights through ethical policymaking. (1985, April 1). PubMed. https://pubmed.ncbi.nlm.nih.gov/10271241
Thompson, I. (1987). Fundamental ethical principles in health care. BMJ, 295(6611), 1461–1465. https://doi.org/10.1136/bmj.295.6611.1461
Moral courage in healthcare: Acting ethically even in the presence of risk | OJIN: The Online Journal of Issues in Nursing. (n.d.). https://ojin.nursingworld.org/MainMenuCategories/ANAMarketplace/ANAPeriodicals/OJIN/TableofContents/Vol152010/No3-Sept-2010/Moral-Courage-and-Risk.[[html
Additional Files
Published
Issue
Section
License
Copyright (c) 2023 Abdul Wahab Yousafzai, Fatimah Saeed
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
